SCHEMBL6246201

SCHEMBL6246201

CCCCCCCCCCCC[SiH](C)CCCCCCCCCCCC

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.53
THRB P10828 1/20 0.53
DNM1 Q05193 7/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HSD17B10 Q99714 1/20 0.40
SLC22A1 O15245 1/20 0.40
EPHX1 P07099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16209969 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL10716954 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL25701964 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL10842394 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1557285 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL28427180 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL10842205 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL8992346 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL7458807 1.00 TSHR (0.53) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL8639212 0.97 TSHR (0.47) TSHRTHRBDNM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551883-A1 SUPPORTED CATALYSTS FOR GAS PHASE OLEFIN POLYMERIZATION Equistar Chemicals, LP (US) 2005-07-13 EP disclosed
US-6884749-B2 Supported catalysts which reduce sheeting in olefin polymerization, process for the preparation and the use thereof EQUISTAR CHEMICALS L.P. (US) 2005-04-26 US disclosed
US-6800777-B2 HYDROCARBON WITH TERMINAL TRIALKYLSILANE ON ONE END AND A SILANE WITH AT LEAST ONE HYDROLYZABLE GROUP ON THE OTHER; BONDS TO CHROMATOGRAPHIC SUBSTRATE SUCH AS SILICA; MINIMAL ?PHASE COLLAPSE? GELEST, INC. 2004-10-05 US disclosed
WO-2004035634-A1 SUPPORTED CATALYSTS FOR GAS PHASE OLEFIN POLYMERIZATION EQUISTAR CHEMICALS, LP (US) 2004-04-29 WO disclosed
US-20040077807-A1 Supported catalysts which reduce sheeting in olefin polymerization, process for the preparation and the use thereof EQUISTAR CHEMICALS L.P. 2004-04-22 US disclosed
US-20020173670-A1 Trialkylsilanes for use in chromatographic applications, substrates including such compounds and methods of producing the same GELSET, INC. 2002-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173670-A1 Trialkylsilanes for use in chromatographic applications, substrates including such compounds and methods of producing the same PFAS, STS, ALK TSHR 1261/4885THRB 1421/4885DNM1 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.